Claim Details
View detailed information about this claim and its related sources.
Claim Information
Complete details about this extracted claim.
- Claim Text
-
A strong foundation in causal human biology coupled with scientific creativity and serendipitous discovery have led to new and expanding approaches for the treatment of neurological conditions such as such as Alzheimer's disease, multiple sclerosis, amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) and others with critical unmet needs.
- Simplified Text
-
Causal human biology scientific creativity serendipitous discovery led to new approaches for treating neurological conditions
- Confidence Score
- 0.500
- Claim Maker
- The author
- Context Type
- Website Article
- Context Details
-
{ "date": null } - Subject Tags
- UUID
- 9fc8a1b9-fea5-4f6a-95b3-03fedbf697b9
- Vector Index
- ✗ No vector
- Created
- September 2, 2025 at 7:15 PM (1 week ago)
- Last Updated
- September 2, 2025 at 7:15 PM (1 week ago)
Original Sources for this Claim (1)
All source submissions that originally contained this claim.
37
claims
🔥
1 week ago
https://www.bms.com/life-and-science/science/renaissance-neuroscience-research-development.html?cid=d_3267515&dclid=CN-sjNPAsI8DFazArQAd_vguSA&gad_source=7
Bristol Myers Squibb is accelerating neuroscience R&D using breakthroughs in human biology, biomarkers, and computational science to improve outcomes for patients with neurological conditions. The company is exploring new approaches to slow disease progression and alleviate symptoms.
Similar Claims (0)
Other claims identified as semantically similar to this one.
No similar claims found
This claim appears to be unique in the system.